Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 416Lymphoma 406Lymphoma, Non-Hodgkin 344Leukemia, Lymphocytic, Chronic, B-Cell 313Lymphoma, Follicular 301Lymphoma, Mantle-Cell 226Lymphoma, B-Cell, Marginal Zone 161Lymphoma, B-Cell 112Leukemia 112Burkitt Lymphoma 110Waldenstrom Macroglobulinemia 99Precursor Cell Lymphoblastic Leukemia-Lymphoma 90Recurrence 82Hodgkin Disease 60Lymphoma, Large-Cell, Immunoblastic 57Neoplasms 33Lymphoma, Large-Cell, Anaplastic 26Myelodysplastic Syndromes 24Leukemia, Myeloid, Acute 24Multiple Myeloma 21Dendritic Cell Sarcoma, Interdigitating 19Intraocular Lymphoma 17Leukemia, Prolymphocytic 15Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 14Lymphoma, T-Cell 14Hematologic Neoplasms 13Lymphoproliferative Disorders 12Leukemia, Hairy Cell 11Leukemia, B-Cell 11Hematologic Diseases 11

Interventions

tocilizumab 1temsirolimus 1siltuximab 1Zidovudine 1Valproic Acid 1Valganciclovir 1Sirolimus 1Rituximab 1Nelfinavir 1Immunoglobulin G 1Genetic Testing 1Disulfides 1Diagnostic Tests, Routine 1Cetuximab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Castleman Disease × Rituximab × Lymphoid × Clear all
NCT00127569 2007-01-12

Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy

French National Agency for Research on AIDS and Viral Hepatitis

Phase 2 Terminated
25 enrolled
LymphoidSarcoma

Castleman Disease, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡